Research Portal

U.S.-listed market research with live data and structured thesis notes.

Powered by AI

Your AI Research
Copilot for Markets

Real-time market intelligence, structured thesis notes, and AI-driven analysis — all in one place.

AI Research Assistant
Side-by-side research view

Compare names across metrics and research quality

Use up to 4 U.S.-listed names from this dashboard to compare valuation, growth, cash flow, balance-sheet strength, and the curated investment case in one place.

1 stocks in current compare
4 max names side by side
24 shared metrics lined up

Build a compare set

Enter comma-separated tickers from the dashboard universe. Duplicate tickers are ignored automatically.

Clear
Compute Stack AI Platforms Power Buildout Robotics
ISRG Robotics

Intuitive Surgical

Surgical robotics leader

Detail page

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Price $447.80
1D change -1.25%
Market cap $158.59B
Sector Healthcare

Shared metric table

Live market metrics plus reported quarterly revenue and profit QoQ rows.

Green and red only apply where direction is meaningful. Quarterly revenue and profit cells inherit the sign of the reported QoQ change, which can swing sharply when the prior quarter included a one-time item.

On smaller screens, swipe this table horizontally to compare the full set.

Metric ISRG
Price $447.80
1D Change -1.25%
Market Cap $158.59B
Enterprise Value $156.21B
Trailing P/E 54.5
Forward P/E 38.0
Price / Sales 15.0
EV / Revenue 14.8
Revenue Growth 23.0%
Earnings Growth 18.8%
Gross Margin 66.3%
Operating Margin 30.9%
Net Margin 28.2%
ROE 17.2%
Free Cash Flow $2.25B
FCF Margin 21.3%
Debt / Equity —
Current Ratio 4.61x
Dividend Yield —
Next Earnings Jul 21, 2026
Quarterly Revenue $2.77B
Revenue QoQ -3.3%
Quarterly Net Income $821.5M
Net Income QoQ +3.4%

ISRG thesis lens

Surgical robotics leader

Why it could benefit

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.